The National Institutes of Health added three "proof-of-concept hubs" to its Research Evaluation and Commercialization Hubs program to help move biomedical discoveries to the market.
The three new hubs are University of Minnesota based in Minneapolis, University of Louisville (Ky.,) and the Long Island Bioscience Hub, which is comprised of Stony Brook University, Cold Spring Harbor Laboratory and Brookhaven National Laboratory.
The awardees will receive $9 million each over the next three years to help foster the development of biomedical discoveries, including therapeutics, preventatives, diagnostics and tools and devices with scientific and commercial potential.
"NIH is committed to ensuring that the American people benefit from the many promising discoveries supported by taxpayers," said Kurt Marek, PhD, program director for REACH and the deputy director of the Office of Translational Alliances and Coordination of the NIH's National Heart, Lung and Blood Institute. "The REACH program will accelerate the translation of those discoveries into new drugs, devices and diagnostics to help patients and improve public health."
More articles on health IT:
Minnesota health system sends patients text messages in Somali and Hmong
Drexel University College of Medicine expands Allscripts service
15% of providers use patient-level predictive analysis